
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused millions of infections and deaths worldwide since its emergence in December 2019, raising a major health concern.
To date, there are no specific and completely effective drugs to the disease. Highly sensitive laboratory diagnostics are therefore critical for controlling the rapidly evolving COVID-19 pandemic, as well as the optimization of clinical care, infection control, and public health interventions. Rapid, accurate and accessible diagnostics are needed for the early detection of pathogens in the preclinical and asymptomatic stages and throughout the follow-up period, until their elimination. Optimization of clinical care and infection control are necessary to limit the disease and contain the impact on hospital workflow; also, public health interventions play a crucial role in preventing the spread of the contagion.
This Methods Collection invites protocols that include, but are not limited to molecular and immunoassay-based tests, new rapid point-of-care diagnostic methods, techniques to identify asymptomatic carriers of COVID-19 during the early stage of infection, new therapeutic approaches or ongoing drug discovery efforts, and finally, management protocols to promptly isolate infected persons. The goal is to present various methods, tools, or technologies in one place that can contribute towards ending the pandemic worldwide.
0 Views
•
2024
•
Maryam Sahi1, Sarah Andersson1, Cecilia Mattson1, Matilda Dale1, Sofia Kagiolglou1, Camilla Hofström2, Helena Persson2, Jonas Klingström3,4, Francesca Chiodi5, Claudia Fredolini1
1Affinity Proteomics-Stockholm Unit, SciLifeLab, Division of Affinity Proteomics, Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), KTH Royal Institute of Technology, 2Human Antibody Therapeutics Unit, SciLifeLab, Division of Drug Discovery and Development, Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), KTH Royal Institute of Technology, 3Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, 4Public Health Agency of Sweden, 5Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet